Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CareView Communications Inc files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
5.97
6.26
6.1
6.29
6.49
7.8
7.9
9.68
8.25
9.02
Cost of revenue
0.1
0.1
0.03
0.03
Gross profit
6.16
5.99
6.26
6.46
Research and development
1.25
1.65
1.43
1.4
1.71
1.71
1.97
2.5
2.35
2.41
Selling and marketing
0.78
0.69
0.39
0.32
0.58
0.55
0.79
1.03
1.14
0.97
General and administrative
3.76
4.01
3.23
4.05
2.72
3.23
3.1
3.24
2.75
2.35
Operating expenses
12.3
12.9
9.75
9.53
8.37
8.95
9.17
10.4
9.83
9.07
Operating income
-6.31
-6.62
-3.65
-3.24
-1.88
-1.15
-1.27
-0.69
-1.58
-0.06
Interest expense
12.6
13.5
12.5
10.9
10.6
8.95
6.26
3.21
3.21
3.21
Interest income
0.02
0.01
0
0
0
0
0
0.02
0.05
0.07
Other non-operating income
-12.4
-10.9
-9.8
-8.93
-4.77
-3.19
-3.15
-3.14
Pre-tax income
-18.7
-20.1
-16.1
-14.1
-11.7
-10.1
-6.04
-3.88
-4.73
-3.19
Income tax
0
0
0.07
-0.03
0.01
Net income to minority interests
-0.05
Net income
-18.6
-20.1
-16.1
-14.1
-11.7
-10.1
-6.04
-3.95
-4.7
-3.2
EBITDA
-4.49
-4.73
-2.37
-2.52
-1.35
-0.57
-0.77
-0.35
-1.33
0.11
EPS, basic
-0.13
-0.14
-0.12
-0.10
-0.08
-0.07
-0.04
-0.01
-0.01
-0.01
EPS, diluted
-0.13
-0.14
-0.12
-0.10
-0.08
-0.07
-0.04
-0.01
-0.01
-0.01
Shares, basic (weighted)
139
139
139
139
139
139
142
448
584
584
Shares, diluted (weighted)
139
139
139
139
139
139
142
448
584
584
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
12.6
4.57
1.2
0.27
0.36
0.66
0.42
1.15
0.76
1.55
Receivables
1.07
1.21
1.28
1.67
1.15
0.93
0.95
1.17
1
1.03
Inventory
0.41
0.35
0.3
0.29
0.42
0.4
Other current assets
0.11
0.59
1.41
0.22
0.24
0.24
0.07
0.34
0.48
0.23
Total current assets
11.3
3.86
3.89
2.16
2.16
2.18
1.84
2.94
2.66
3.21
Property, plant and equipment
4.15
3.32
2.49
1.98
1.59
1.14
0.64
0.32
0.18
0.1
Lease right-of-use assets
0.09
0.66
0.56
0.43
0.29
0.13
0.75
Intangible assets
0.61
0.67
0.75
0.83
0.9
0.91
0.82
0.41
0.4
0.37
Other non-current assets
2.17
1.77
1.81
1.16
1.75
1.77
1.46
0.3
0.26
0.21
Total assets
21.5
12.1
8.18
5.29
5.5
5.08
3.95
4.26
3.62
4.64
Accounts payable
0.2
0.37
0.51
0.44
0.44
0.41
0.65
0.6
0.47
0.31
Accrued liabilities
6.84
Deferred revenue
0.26
0.47
0.98
0.89
1.75
2.41
2.41
Short-term debt
14.2
Total current liabilities
1.89
9.65
17.4
25.6
74.2
89.3
66.1
40.2
43.8
46.7
Long-term debt
0.44
0.51
4.18
3.66
1.83
Lease liabilities
0.56
0.45
0.31
0.14
0
0.72
Other non-current liabilities
0.04
0.02
0.18
0.25
0
Total liabilities
64.2
74.3
86
97
109
118
80.6
40.5
44.1
47.7
Total debt
14.2
Paid-in capital
84.1
83.6
84
84.2
84.4
85.1
127
171
172
172
Retained earnings
-126
-146
-162
-176
-188
-198
-204
-208
-213
-216
Shareholders' equity
-42.7
-62.2
-77.8
-91.7
-103
-113
-76.7
-36.3
-40.4
-43
Minority interests
-0.55
Total equity
-42.7
-62.2
-77.8
-91.7
-103
-113
-76.7
-36.3
-40.4
-43
Total liabilities and equity
21.5
12.1
8.18
5.29
5.5
5.08
3.95
4.26
3.62
4.64
Shares outstanding
139
139
139
139
139
142
142
584
584
584
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-18.7
-20.1
-16.1
-14.1
-11.7
-10.1
-6.04
-3.95
-4.7
-3.2
Depreciation and amortization
1.82
1.89
1.28
0.72
0.53
0.58
0.5
0.33
0.25
0.17
Stock-based compensation
0.72
0.4
0.26
0.16
0.16
0.22
0.23
0.15
Deferred income tax
0
0
0
Change in receivables
0.11
-0.14
-0.07
-0.38
0.52
0.21
-0.02
-0.22
0.17
-0.03
Change in inventory
-0.41
0.06
0.05
0.01
-0.12
0.02
Change in payables
-0.14
0.17
0.14
-0.07
0
-0.03
0.24
-0.05
-0.13
-0.16
Cash from operations
-6.07
-6.26
-4.84
-1.44
-0.79
0.68
-0.37
0.7
-0.31
0.81
Capital expenditures
-1.43
-0.99
-0.43
-0.16
-0.14
-0.1
-0.01
-0.02
-0.05
-0.01
Cash from investing
-1.52
-1.26
-0.62
-0.34
-0.3
-0.23
-0.01
-0.06
-0.07
-0.02
Debt repaid
-0.02
-0.01
0
Cash from financing
-0
-0.5
2.85
0.1
1.18
-0.15
0.24
-0.02
-0.01
0
Net change in cash
-7.59
-8.02
-2.62
-1.68
0.09
0.3
-0.14
0.63
-0.39
0.79
Free cash flow
-7.5
-7.25
-5.27
-1.59
-0.93
0.58
-0.38
0.69
-0.35
0.8
Interest paid
2.72
2.7
2.03
0.15
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.04 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Operating margin
4.4%
Operating income / revenue.
EBITDA margin
6.0%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-28.9%
Pre-tax income / revenue.
Net margin
-28.9%
Net income / revenue.
FCF margin
1.8%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
2.1%
Cash from operations / revenue.
Return on assets (ROA)
-46.3%
Net income / average total assets.
R&D / revenue
26.9%
Research and development expense / revenue.
Capex / revenue
0.4%
Capital expenditures / revenue.
D&A / revenue
1.6%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
9.3%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
4.5%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
6.8%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
28.1%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
5.5%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-3.4%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
0.0%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
60.3%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
33.2%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.09x
Current assets / current liabilities.
Quick ratio
0.08x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.04x
(Cash + short-term investments) / current liabilities.
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.00
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.02
Revenue / diluted weighted shares.
FCF per share
$0.00
Free cash flow / diluted weighted shares.
Operating cash flow per share
$0.00
Cash from operations / diluted weighted shares.
Book value per share
-$0.07
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
2.17x
Market cap / revenue.
P/FCF
123x
Market cap / free cash flow. Only when free cash flow is positive.
P/OCF
102x
Market cap / cash from operations, when positive.
EV/Sales
1.96x
Enterprise value / revenue.
EV/EBIT
44.2x
Enterprise value / operating income, when both are positive.
EV/EBITDA
32.7x
Enterprise value / EBITDA, when both are positive.
EV/FCF
112x
Enterprise value / free cash flow, when both are positive.
FCF yield
0.8%
Free cash flow / market cap.
Earnings yield
-13.4%
Net income / market cap (the inverse of P/E).
What was CareView Communications Inc's revenue in fiscal 2025?
CareView Communications Inc reported revenue of $9.0M for fiscal 2025, 9.3% higher than the year before.
Was CareView Communications Inc profitable in fiscal 2025?
No. It reported a net loss of $3.2M.
How much free cash flow did CareView Communications Inc generate in fiscal 2025?
Cash from operations of $805.2K minus capital expenditures of $8.7K left free cash flow of $796.5K.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.